Capillary Olanzapine Sampling Method validatiOn Study

Capillary Olanzapine Sampling Method validatiOn Study - COSMOS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56914

Enrollment

Registered

2024-03-26

Start date

2025-07-24

Completion date

Unknown

Last updated

2025-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concentration of olanzapine in blood Concentration of olanzapine in blood

Interventions

&nbsp

capillaire microsampling&nbsp

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Age 18 to 64 - Treated with olanzapine - Signed informed consent

Exclusion criteria

Exclusion criteria: - Co-medication: lithium - Unable to draw blood samples for study purposes - If the clinician considers the patient to be mentally incompetent in decision making

Design outcomes

Primary

Measure	Time frame
Comparison of capillary microsampling to venepunctures to clinically validate capillary microsampling of olanzapine.	—

Secondary

Measure	Time frame
To obtain patient*s perspectives on the finger prick capillary microsampling compared to the standard method by venepuncture.	—

Countries

Netherlands

Contacts

Public ContactT.M. Bosch

Maasstad Ziekenhuis

boscht@maasstadziekenhuis.nl+31 (0) 10 291 2930

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)